Thursday, May 19, 2022 7:53:55 AM
Maybe someone can discover how the Mikaelian baby is progressing in negotiations with Farmatsevtik as he/she tours Uzbekistan, Kyrgyzstan, and Armenia on funds supplied by shareholders? I suppose the baby can't possibly deliver less revenues than Father and Son?
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
